143563-93-3

Upstream product

• 143563-19-3 methyl 3-C-<(benzoyloxy)methyl>-5-O-(p-bromobenzyl)-2,3-dideoxy-D-erythro-pentofuranoside 
• 108267-97-6 (2S,3R)-3-<<(4-bromobenzyl)oxy>methyl>oxirane-2-methanol 
• 98-88-4 benzoyl chloride 
• 132235-67-7 (2S,3R)-4-O-benzoyl-1-O-(p-bromobenzyl)-3-(2'-propenyl)-1,2,4-butanetriol 
• 132235-65-5 (2S,3R)-1-O-(p-bromobenzyl)-3-(2'-propenyl)-1,2,4-butanetriol 

Downstream Products

• 132235-78-0 C₂₅H₂₃N₅O₅ 
• 132235-77-9 C₂₅H₂₃N₅O₅ 

Relevant academic research and scientific papers

Nucleosides and nucleotide analogues, pharmaceutical composition and processes for the preparation of the compounds

A compound of the formula STR1 wherein the radicals A, X, R1, R2 and R3 are defined as follows: STR2 R2 : H; or R2 constitutes together with R3 with a carbon - carbon bond R3 : H; F; Cl; Br; I; N3 ; CN; C CH; OH; OCH3 ; CH2 OH; and when R3 is F; Cl; Br; I; N3 ; CN; C CH; OH; OCH3 or CH2 OH it may have either the cis-configuration or trans-configuration relative to the hydroxymethyl function at position 4', or R3 constitutes together with R2 a carbon - carbon bond, and therapeutically acceptable salts thereof, for use in therapy, in particular for the treatment of HIV infections.